ISSN: 0887-6924

Leukemia Q1 Unclaimed

Nature Publishing Group United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Leukemia publishes high quality, peer reviewed research that covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance. Topics of interest include oncogenes, growth factors, stem cells, leukemia genomics, cell cycle, signal transduction, molecular targets for therapy and more. We publish a range of content types including original research articles, reviews, letters, correspondence and commen It has an SJR impact factor of 3,376.

Leukemia focuses its scope in these topics and keywords: leukemia, myeloid, cell, multiple, lymphoblastic, myeloma, cells, stem, relapse, t, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: Monthly

Categories: Anesthesiology and Pain Medicine (Q1) Cancer Research (Q1) Hematology (Q1) Oncology (Q1)

Price

3690 €

Inmediate OA

NPD

Embargoed OA

2474 €

Non OA

Metrics

3,376

SJR Impact factor

211

H Index

344

Total Docs (Last Year)

1098

Total Docs (3 years)

13725

Total Refs

8402

Total Cites (3 years)

895

Citable Docs (3 years)

7.59

Cites/Doc (2 years)

39.9

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

CA - A Cancer Journal for Clinicians Q1
Journal of Hematology and Oncology Q1
Blood Q1
The Lancet Haematology Q1
Blood Cancer Journal Q1

Compare this journals

Aims and Scope

Best articles by citations

Treatment of neutropenia-related fungal infections with granulocyte colony-stimulating factor-elicited white blood cell transfusions: a pilot study

Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93

Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells

JAK2 p.G571S in B-cell precursor acute lymphoblastic leukemia: a synergizing germline susceptibility

Therapeutic renaissance of thalidomide in the treatment of haematological malignancies

Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia

V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation

Erratum: Clinical significance of central nervous system involvement at diagnosis of pediatric acute myeloid leukaemia: a single institution's experience

Chromosomal abnormalities clustering in multiple myeloma reveals cytogenetic subgroups with nonrandom acquisition of chromosomal changes

Co-existence of pseudo-Chediak-Higashi anomaly and double minutes containing C-MYC oncogene in three patients with AML M2

Erratum: Correction to: Commentary: Progress in chimerism analysis in childhood malignancies -the dilemma of biostatistical considerations and ethical implications

Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells

SHOW MORE ARTICLES

Insights into the multistep transformation process of lymphomas: IgH-associated translocations and tumor suppressor gene mutations in clonally related composite Hodgkin's and non-Hodgkin's lymphomas

Response to Anguita et al

Role of high-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC)

Comparative analysis of the effects of sample source and test methodology on the assessment of protein expression in acute myelogenous leukemia

Low frequency clonal mutations recoverable by deep sequencing in patients with aplastic anemia

Interactive ChimerTrack software facilitates computation, visual displays and long-term tracking of chimeric status based on STRs

p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells

Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical-biological situations

First case of plasma-cell leukemia co-existing with human immunodeficiency virus infection

Response to Chand et al

Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach